Cargando…

Correction: Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314660/ https://www.ncbi.nlm.nih.gov/pubmed/37399364 http://dx.doi.org/10.1136/rmdopen-2022-002507corr1

Ejemplares similares

Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
por: De Miguel, Eugenio, et al.
Publicado: (2022)

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
por: Monti, Sara, et al.
Publicado: (2019)

Validity of the EULAR recommendations on the use of ultrasound in the diagnosis of giant cell arteritis
por: Fernández-Fernández, Elisa, et al.
Publicado: (2022)

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
por: Águeda, Ana F, et al.
Publicado: (2019)

Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations
por: Duftner, Christina, et al.
Publicado: (2018)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations
por: Bosch, Philipp, et al.
Publicado: (2023)

Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
por: Molina-Collada, Juan, et al.
Publicado: (2023)

Mimickers of Large Vessel Giant Cell Arteritis
por: Ramon, André, et al.
Publicado: (2022)

Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria
por: Andel, Peter M., et al.
Publicado: (2023)

Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis
por: Monjo-Henry, Irene, et al.
Publicado: (2023)

Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force
por: Sanchez-Alvarez, Catalina, et al.
Publicado: (2023)

Correction: Need and value of targeted immunosuppressive therapy in giant cell arteritis
Publicado: (2022)

HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study
por: Kushimoto, Kazuo, et al.
Publicado: (2021)

Positron Emission Computed Tomography Spectrum of Large Vessel Vasculitis in a Tertiary Center: Differences in 18F-fluorodeoxyglucose Uptake between Large Vessel Vasculitis with Predominant Cranial and Extracranial Giant Cell Arteritis Phenotypes
por: Heras-Recuero, Elena, et al.
Publicado: (2023)

Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis
por: Dao, Diem-Phuong, et al.
Publicado: (2021)

Giant cell arteritis with stroke and systemic diffuse vasculitis
por: Lu, C, et al.
Publicado: (2022)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Mazumder, Rifat, et al.
Publicado: (2021)

Large-vessel involvement is predictive of multiple relapses in giant cell arteritis
por: de Mornac, Donatienne, et al.
Publicado: (2021)

Correction: Development of generic core competences of health professionals in rheumatology: a systematic literature review informing the 2018 EULAR recommendations
Publicado: (2019)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
por: Yates, Max, et al.
Publicado: (2017)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Reply
por: Karabayas, Maira
Publicado: (2021)

Giant cell arteritis: A rare cause of posterior vasculitis
por: Moschos, Marilita M, et al.
Publicado: (2009)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group
por: Chrysidis, Stavros, et al.
Publicado: (2018)

Large vessel vasculitis
por: Gulati, Ashima, et al.
Publicado: (2009)

Extra- and Intracranial Cerebral Vasculitis in Giant Cell Arteritis: An Observational Study
Publicado: (2015)

Extra- and Intracranial Cerebral Vasculitis in Giant Cell Arteritis: An Observational Study
por: Larivière, Delphine, et al.
Publicado: (2014)

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis
por: Haaversen, Anne Bull, et al.
Publicado: (2023)

EULAR recommendations for intra-articular therapies
por: Uson, Jacqueline, et al.
Publicado: (2021)

Ultrasound for diagnosis and follow-up of chronic axillary vasculitis in patients with long-standing giant cell arteritis
por: Bosch, Philipp, et al.
Publicado: (2021)

Correction to: Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study
por: Brekke, L. K., et al.
Publicado: (2018)

Covid-19-vaccine-pfizer-biontech: Large-vessel giant cell arteritis: case report
Publicado: (2022)

Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis
por: de Mornac, Donatienne, et al.
Publicado: (2021)

External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic
por: van Nieuwland, Marieke, et al.
Publicado: (2023)

Correction: Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study
por: Jamilloux, Yvan, et al.
Publicado: (2013)

Large-Vessel Giant Cell Arteritis following COVID-19—What Can HLA Typing Reveal?
por: Stojanovic, Maja, et al.
Publicado: (2023)

Correction: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Publicado: (2020)

Pericarditis Revealing Large Vessel Vasculitis
por: Couturier, Bruno, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4u7j4o6d8vuvpcknt2dt6f0cdt